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Title: Possible hypoxia signaling induced alteration of glucose homeostasis in rats exposed to 
chronic intermittent hypoxia - Role of antioxidant (vitamin C) and Ca2+ channel blocker 
(Cilnidipine) 
 
Abstract: 
Background: Hyperglycemia founds to be a regulator of HIF-ĮJHQHH[SUHVVLRQEXW WKHUHJXODWLRQRI+,)-ĮRQ
glucose homeostasis is unclear.  Objective: To determine whether chronic intermittent hypoxia (CIH) alters glucose 
regulation and such alterations can revert through treatments with either antioxidant (vitamin c) or calcium channel 
blocker (cilnidipine) in male albino rats. Methods:  The rats were divided into six groups i.e. normoxia (21 % oxygen), 
CIH (10% oxygen with cycle time 3:1.5; 8h/day), normoxia with vitamin c (50 mg /100g. b.wt, orally), CIH with 
vitamin c, normoxia with cilnidipine (1 mg/kg/day; ip) and CIH with cilnidipine. Serum MDA, HIF-ĮIDVWLQJSODVPD
glucose, insulin, GTT, HOMA-IR and insulinogenic index were evaluated. Results:  Serum HIF-Į and MDA 
concentration in rats exposed to CIH   increased significantly whereas simultaneous CIH with vitamin c and CIH with 
cilnidipine treatment show reversion of both serum HIF- ĮDQG0'$FRQFHQWUDWLRQVWRZDUGVQRUPR[LFVWDWXV&,+
rats showed increased fasting glucose level with unchanged plasma insulin level but both vitamin c and cilnidipine 
treatment improved the status. Elevated HOMA-IR and insulinogenic index along with impaired GTT were found in 
CIH groups although vitamin c and cilnidipine improved the glucose homeostasis in CIH exposed rats. Conclusion: 
CIH induces over production of reactive oxygen species as well as hyper activities of sympathetic N-type Ca2+ 
channels possibly through HIF 1-ĮH[SUHVVLRQDQGLQIOXHQFHRQLQVXOLQVLJQDOLQJE\FDusing hyperglycemia, glucose 
intolerance and insulin resistance in rats. Simultaneous treatment with vitamin c or cilnidipine improves glucose 
homeostasis in CIH exposed rats.  
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1. INTRODUCTION 
Hypoxia usually classified into sustained or intermittent variant and may be either acute or chronic in exposure. 
Normally chronic sustained hypoxia may be due to physiological or pathological reasons but chronic intermittent 
hypoxia (CIH) is always pathological by nature.  
In general, the effect of hypoxia on the physiological system is controlled by hypoxia inducible factor-ĮHIF-Į
protein. HIF-Į is a transcription factor and remained stable in presence of low oxygen tension and facilitates an 
adaptive mechanism inside the cell against hypoxia exposure. Under hypoxic status the proline residues are not 
hydroxylated by prolyl hydroxylase (PHD) hence hif-ĮUHPDLQV VWDEOHDQGQRWGHJUDGHG7KLVVWDELOL]HG+,)ĮLV
translocated in the nucleus where it dimerises with HIF-ȕDQGDVVRFLDWHVZLWKRWKHUIDFWRUVOLNH&5(% - binding 
protein, CBP/p300 [1-2]. Chronic intermittent hypoxia is commonly seen in obstructive sleep apnoea. It is associated 
with cardiovascular diseases, hypertension and impaired glucose homeostasis. Several experiments on animal models 
revealed a definite correlation between CIH and metabolic impairments like glucose intolerance, decrease insulin 
sensitivity or altered insulin secretary functions etc (Wahren J 2007; Carreras A, 2012). Study reveals that CIH 
influences reactive oxygen species (ROS) production which in further stimulates HIF-1 Į gene expression 
consequently continuance of oxidative stress. This effect augments further production of HIF-1 Į[3]. Relationship 
was established between CIH and vascular proliferation or increase of vascular reactivity or right heart failure [4]. 
Recent observation reveals that CIH activates NADPH oxidase which is very important for HIF-1 expression and ROS 
production. NADPH oxidase hyperactivities also changes intracellular calcium homeostasis and stimulate further HIF 
1 production, subsequently resulting in more ROS generation. High concentration of ROS excites carotid bodies and 
adrenal medulla that influence on adrenergic activities via chemoreflex and alters catecholamine status [5]. 
A relation between increased sympathetic activation and hypoxia with consequent impaired glucose homeostasis 
provides a thought of possible protective counteraction with N-type calcium channel blockers which are normally 
used to control hypertension or heart diseases [6].  
An interesting study showed that fasting glycemia become corrected after withdrawal of two weeks CIH exposure but 
insulin resistance and beta cell abnormalities remain unchanged [7]  Although the link between CIH and altered 
glucose metabolism is understood but exact mechanism of impaired glucose tolerance during CIH exposure is yet to 
establish.  
Thus the present study was undertaken to find out the CIH induced alteration of hypoxia signaling pathways and its 
possible impact on glucose metabolism. The objectives of the study were also to determine whether such alterations 
revert through treatments with either antioxidant (vitamin C) or fourth generation L/N type calcium channel blocker 
(cilnidipine) in male albino rats.  
 
 
 
 
2. MATERIALS AND METHODS 
Animals 
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Adult (age 60±70 days) laboratory-bred male Wister rats, weighing 180 ± 20g fed with laboratory stock diet and water 
ad libitum were acclimatized for 7 days to the laboratory conditions at 22°±24°C and a 12 h light: Dark cycle. The 
acclimatized rats were divided into six groups of six rats each. Three rats were kept in each metabolic wire cage (60 
cm × 30 cm × 20 cm). Animals were taken care of as per the CPCSEA guidelines and the experimental protocol was 
duly approved by Institutional Animal Ethics Committee. 
 
Experimental Groups 
Group I served as control (normoxia, 21 % oxygen), group II rats were exposed to intermittent hypoxia (CIH, 10 % 
O2 and 90% N2) for 21 days, group III rats were supplemented with vitamin C ( normoxia + vitamin C, dosage 50 mg 
/ 100g. b.wt, orally ) [8] for 21 days, group IV rats  were exposed to intermittent hypoxia and vitamin C 
supplementation (CIH + vitamin C) for 21 days), group V rats were treated with calcium channel blocker cilnidipine 
(normoxia + cilnidipine, dosage 1 mg/kg/day; ip) [9] for 21 days ( and group VI rats exposed to CIH and 
simultaneously treated with cilnidipine ( CIH + cilnidipine) for 21 days.  
 
Exposure of Animals to Chronic Intermittent Hypoxia 
For CIH exposure, caged rats (3 per cage) were put inside a 300-liter acrylic chamber, which held a maximum of 4 
cages (12 rats). The rats were placed in hypoxic chamber (10 % O2 and 90% N2; the cycle time of intermittent hypoxia 
was 180 sec for the hypoxia and 90sec for normoxia respectively) for 8 hours from 9:00-17:00 per day for 21 days 
[10]. The hypoxic environment was established with the inflow of a mixture of room air and nitrogen that was 
regulated by an oxygen analyzer (model 175518A, Gold Edition, Vacuum Med). CO2 was absorbed by soda lime 27 
granules, and excess humidity was removed by a desiccators. Temperature was maintained at 24-26°C. The chamber 
was opened twice a week for 1 h to clean the cages and replenish food and water. As intermittent hypoxia causes 
weight loss hence a dietary pair fed system between normoxic groups and intermittent hypoxic groups were maintained 
throughout the experimental period to keep the same body weight trajectory. All the animals were sacrificed on the 
22nd day early morning between 09:00h ± 11:00h to avoid diurnal rhythm on animals [11].   
 
Gravimetry  
The body weight of all the rats was recorded on the day 1 of the hypoxia treatment and the day of sacrifice in a single 
pan electronic balance (ATCO. Model D2RS02-W).  
 
Biochemical analysis 
Serum HIF-Į was estimated by using commercially available ELISA kit (KT-17920, Kamiya, Biomedical 
Company,USA) and serum malondialdehyde (MDA), a marker of oxidative stress was estimated by Kei Satoh method 
[12]. 
Glucose homeostasis: Fasting blood glucose was estimated by Accu-check active (Roche diagnostics, Germany) at 0 
and 30 minutes after glucose administration (1g/kg b.wt.). Blood samples of all the six groups were collected and 
transferred to heparin containing microtubules which were placed in an ice bath for 20 minutes and centrifuged for 7 
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minutes at 4000 rpm and then plasma insulin concentrations were also measured at 0 and 30 minutes after glucose 
administration by ELISA kits (ERINS, Thermo Fisher Scientific, Life technologies). Homeostasis model assessment-
insulin resistance (HOMA-IR) were evaluated by using the following formula:-HOMA-IR = (fasting plasma insulin 
(ȝg/L)×fasting blood glucose (mg/dL) / 22.5) [13-14]. Insulinogenic - index  were estimated after  glucose (1g/kg  
b.wt.) was administrated orally, and blood samples were drawn with heparinized capillary tubes from the retro-orbital 
plexus at 0 and 30 minutes for measurement of blood glucose and plasma insulin concentrations. Insulinogenic-index 
was calculated by using the following equation:- 
Insulinogenic-index = (30 min plasma insulin-fasting plasma insulin) / (30 min blood glucose-fasting blood glucose)[ 
13,15-16]. Oral glucose tolerance tests (OGTT) were done by evaluating fasting blood sugar level (FBS) in the rats of 
all groups. The rats of all six groups were orally treated with 0.35 mg/100g b. wt. of glucose.. Blood samples were 
collected from the rat tail vein just prior to glucose administration (0.0 h) and at 0.5 h, 1.0 h, 1.5 h and 2.0 h after 
glucose loading. Blood glucose levels were measured immediately by using glucometer (Accu-check active, Roche 
Diagnostics, Mannheim, 
Germany)[17].     
Statistical Analysis: 
Results were presented as mean ± standard deviation values for each group. Statistical analysis of the data was 
performed to determine the significance of inter-group differences by one-ZD\DQDO\VLV$129$IROORZHGE\³post-
hoc t-WHVW´ 
 
3. RESULTS 
Table 1 showed CIH exposed rats gained least body weight (%) during 21 days experimental period among all the 
groups. Both vitamin C supplemented and cilnidipine treated CIH exposed rats showed uniform or greater % body 
weight gain with normoxic rats.  
 
Table 1 Effect of chronic intermittent hypoxia (CIH) and simultaneous supplementation of vitamin C (50 mg / 100g. 
b.wt, orally) and cilnidipine (1 mg/kg/day; ip) on body weight changes in rats. 
 
Parameters Normoxia CIH Nomoxia + Vitamin C 
CIH + 
Vitamin C 
Normoxia + 
Cilnidipine 
CIH + 
Cilnidipine 
Initial Body 
Weight (g) 187.5 ± 5.00
a
 190.5 ±8.25a 185.17 ± 7.50a 185.50 ± 6.25a 187.75±8.25
a
 187 ± 5.00a 
Final Body 
Weight (g) 
215.25 ± 
12.50a 
200.08 ± 
5.70b 
220.00 ± 
10.50c 205.50  ±5.50
b
 215.50±15.50a 215.50±10.50a 
%  Body 
Weight gain 12.50 ± 3.50
a
 5.25 ± 1.00b 17.50 ± 2.24c 11.00 ± 2.50a 13.50 ± 2.50a 12.40 ± 2.00a 
Horizontal values are the mean ± SD of six observations in each group. In each row, values with different 
superscripts (a, b, c, d) are significantly different from each other (p<0.05).  
Fig.1 shows a significant elevation of serum HIF-Įconcentration in rats exposed to CIH as compared to normoxic 
rats. However simultaneous treatment with either vitamin C (dosage 50 mg / 100g. b.wt, orally) or cilnidipine (dosage 
1 mg/kg/day; ip) on CIH exposed rats significantly decreases serum HIF-Į concentration as compared to CIH 
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exposed rats. Vitamin C dosage selected here is referred to as high dose and cilnidipine is a unique dihydropyridine 
derivative L-type Ca2+ channel blocker with an inhibitory action on the sympathetic N-type Ca2+ channels. It has 
superior cardioprotective, renoprotective and neuroprotective effects.  
Further to note that serum HIF-Į concentration significantly reduces in cilnidipine treated CIH exposed rats as 
compared to vitamin C supplemented CIH exposed rats.  
 
 
Fig.1: HIF-Įconcentration in different experimental groups exposed to chronic intermittent hypoxia (CIH) 
and simultaneous supplementation of vitamin C (50 mg / 100g. b.wt, orally) and cilnidipine (1 mg/kg/day; ip). 
Values with different superscripts (a, b, c, d) are significantly different from each other (p<0.05); n = 6 in each 
group. 
Fig.2 shows a significant increase of MDA concentration in CIH exposed rats in comparison to normoxic animals. 
Rats treated with either vitamin C or cilnidipine showed significant reduction of serum MDA level as compared to 
CIH exposed rats. Interestingly vitamin C supplemented CIH exposed rats showed significant decrease of serum MDA 
level in comparison to cilnidipine treated CIH exposed rats.  
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Fig. 2: Malondealdehyde (MDA) concentration in different experimental groups exposed to chronic 
intermittent hypoxia (CIH) and simultaneous supplementation of vitamin C (50 mg / 100g. b.wt, orally) and 
cilnidipine (1 mg/kg/day; ip). Values with different superscripts (a, b, c, d) are significantly different from each 
other (p<0.05); n = 6 in each group. 
Table 2 shows a significant rise in fasting blood glucose concentration in rats exposed to chronic intermittent hypoxia 
(CIH) as compared to normoxic group rats whereas rats treated with either vitamin C or cilnidipine showed remarkable 
improvement in fasting blood glucose level. Fasting plasma insulin levels in all the six groups remained unchanged 
whether in case of CIH exposed rats or rats treated with either vitamin C or cilnidipine simultaneously. CIH group 
also showed significant increase of HOMA-IR and insulinogenic-index values as compared to normoxic group.  In 
case of simultaneous vitamin C treated CIH exposed rats or cilnidipine treated CIH exposed rats, both HOMA-IR and 
insulinogenic-index decreased significantly as compared to CIH alone exposed rats.  Fig.3 depicts a comparative 
analysis of percent change differences of HOMA-IR and insulinogenic ± index in all the experimental groups as 
compared to normoxia group of rats. The results showed percent change increase of both HOMA-IR (61.8%) and 
insulinogenic-index (71.87%) in CIH exposed group. In case of CIH exposed rats simultaneously treated with vitamin 
C and cilnidipine showed remarkable improvement of percent change differences in both HOMA-IR (vitamin C, 
28.8% ; cilnidipine, 23.90%) and insulinogenic ± index ( vitamin C, 25.0% ; cilnidipine, 6.25%).  
0
1
2
3
4
5
6
Normoxia CIH Normoxia +
Vitamin C
CIH +
Vitamin C
Normoxia +
Cilnidipine
CIH +
Cilnidipine
M
D
A
 (
µ
m
o
l/
L)
a
b
a
c
a
d
7 
 
 
 
Table 2:  Effect of chronic intermittent hypoxia (CIH) and simultaneous supplementation of vitamin C (50 mg / 100g. b.wt, orally) and cilnidipine (1 mg/kg/day; 
ip) on glucose homeostasis (blood glucose, plasma insulin, HOMA-IR and insulinogenic response) in rats after 21 days treatment 
 
Horizontal values are the mean ± SD of six observations in each group. In each row, values with different superscripts (a, b, c, d) are significantly different from 
each other (p<0.05).  
 
 
 
 
 
 
 
Parameters Normoxia Chronic 
Inrtermittent 
Hypoxia (CIH) 
Normoxia + 
Vitamin C 
CIH + Vitamin C Normoxia + 
Cilnidipine 
CIH + 
Cilnidipine 
µW¶
value 
df µS¶
value 
Fasting blood 
glucose (mg/dl) 
75.00 ± 2.37a 128.45 ± 3.58 b 80.00 ± 3.30 a 100.00 ± 5.20 c 77.00 ± 2.82 a 91.23 ± 4.65d 3.54 5 0.0000 
Fasting plasma 
,QVXOLQȝJ/ 
1.00 ± 0.17 a 1.01± 0.19 a 1.04 ±  0.11a 1.03 ± 0.22 a 1.03  ± 0.18 a 0.98  ± 0.14 a 0.58 5 0.2671 
HOMA-IR 3.30 + 0.11 a 5.34 + 0.55 b 3.42 + 0.35 a 4.23 + 0.44 c 3.26 ± 0.16 a 4.09 ± 0.26 d 2.64 5 0.0015 
Insulinogenic -
index 
0.0032 + 0.0005 a 0.0055 +  
0.0005 b 
0.0034 + 
0.0001a 
0.0040 + 0.0002 c 0.0033 ± 
0.0004 a 
0.0034 + 
0.0003 a 
2.45 5 0.0018 
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The results also reveal that N-type calcium channel blocker cilnidipine regulates glucose metabolism better than 
antioxidant vitamin C on rats exposed to chronic intermittent hypoxia.  
 
 Fig. 3:  Percent change chart of HOMA-IR and Insulinogenic index in rats exposed to chronic  intermittent 
hypoxia (CIH) and simultaneous treatment with vitamin C and cildinipine. E-1, Normoxia vs CIH; E-2, Normoxia 
vs Vitamin C; E-3, Normoxia vs CIH + Vitamin C; E-4, Normoxia vs  Cilnidipine; E-5, Normoxia vs CIH + 
Cilnidipine; n = 6 in each group. 
 
 
           Fig. 4: Effect of chronic intermittent hypoxia (CIH) and simultaneous supplementation of 
                      vitamin C (50 mg / 100g. b.wt, orally) and cilnidipine (1 mg/kg/day; ip) on oral glucose 
                      tolerance test (OGTT) in rats ( n=6 in each group) after 21 days  treatment 
 
Fig.4 shows OGTT of all the six groups of rats. CIH exposed rats showed impaired glucose tolerance by reaching the 
peak concentration at 1.5h and even at 2h the glucose concentration did not come back to baseline. However the CIH 
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exposed rats treated simultaneously with either vitamin C or cilnidipine showed better glucose tolerance in fact 
cilnidipine treated CIH exposed animals were having superior glucose tolerance than vitamin C treatment group. 
 
4. DISCUSSION 
The present study shows that exposure of chronic intermittent hypoxia induces hyperglycemia, glucose intolerance 
and insulin resistance in rats. These changes are connected with elevated levels of HIF-Į concentration and 
simultaneous treatment with antioxidant (vitamin C) and N-type calcium channel blocker (cilnidipine) ameliorate 
overall insulin sensitivities. There are variable reports on intermittent hypoxia induced glucose metabolism. Studies 
reveal that both chronic and acute intermittent hypoxia can increase gluconeogenesis, increase hepatic glucose output, 
increased sympathetic drives, increased circulating steroids and enhanced HIF-Įconcentration. Increase level of 
HIF-Įconcentration may in turn influences transcription of multiple enzymes require for gluconeogenesis [7]. 
Increase HIF-Į concentration due to CIH in our study indicates oxygen-sensing by carotid bodies and perhaps 
generate ROS besides regulating sympathetic adrenergic drive. One of the characteristic features of CIH is generation 
of ROS probably due to repetitive re-oxygenation which can also regulate intracellular hypoxia transcription factors 
[18]. The present study shows that CIH leads to formation of ROS indicated by increasing serum MDA level in CIH 
exposed groups and effectively counteracted by both antioxidant (vitamin C ) and  calcium channel blocker 
(cilnidipine). Upon excessive generation of ROS by CIH may possibly react with circulatory nitric oxide (NO), a 
crucial vasodilator and produce peroxynitrite. This mechanism impair NO dependent vasodilatation by reducing 
bioavailability of NO in circulatory system [19]. Several studies reported that moderate intermittent hypoxia exposure 
causes increase in lipid peroxidation including superoxide and hydrogen peroxide generation in different metabolically 
active tissues [20]. The role of HIF-Įon activation of ROS in the cell is established and it is also noticed that the 
binding site of these redox-regulated transcription factors are situated in the promoter region of antioxidants encoded 
genes [21].. It is suggested that the production of ROS during intermittent hypoxia may be due to a link between HIF-
Įand NF-Nȕ which may be well controlled by antioxidants [22]. Vitamin C supplementation in rats exposed to CIH 
in our present study showed a remarkable improvement of both HIF-Įand MDA concentration probably supported 
this link.  
The role of calcium channel blocker- cilnidipine on HIF-Įand MDA regulation are also found to be interesting. 
Cilnidipine is having both L- and N-type calcium channel blocking actions hence it is useful to inhibit sympathetic 
overdrive and reduces norepinephrine release from adrenergic nerve endings. This makes cilnidipine a 
cardioprotective agent. High concentration of serum HIF-Įand MDA due to CIH suggest sympathetic over activities 
and excessive ROS production [23]. Simultaneous treatment with cilnidipine in our study showed a remarkable 
improvement of both HIF-Įand MDA level which clearly indicates cilnidipine perhaps decreased sympathetic over 
activities and generation of excessive ROS. Our findings are further supported by the previous observation that 
cilnidipine influence on HIF-Įexpression is dependent on O2 concentration [24]. 
One of the serious implications of CIH is the balance between vasoconstriction and vasodilatation as reports said that 
most of the cases CIH usually induce vasoconstrictions but in some cases vasodilatation also. CIH possibly stimulate 
chemoreceptor activity and subsequently vasoconstriction and systemic hypertension. Beside the elevation of 
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chemoreflex by CIH, an impairment of baroreflex is also the possibility of for increase in vasoconstriction due to CIH 
[25-26].   
The interesting and novel findings of this investigation are the decreased insulin sensitivities and increase serum HIF-
Į concentration due to the exposure of CIH. These findings are supported by several previous observations of 
impaired glucose tolerance with increase insulin resistance (IR) during chronic intermittent hypoxia on animals and 
humans [3,27].  
It is unlikely that increased sympathetic activation is entirely responsible for hypoxia induced insulin resistance, and 
thus our observation on increase ROS generation indicated by increase MDA level in CIH group too may be 
considered as influential contributor for altering insulin signaling and developing insulin resistance in rats [6].  
Another interesting observation in this study is to find out the treatment of cilnidipine as a better regulator of glucose 
homeostasis and HIF-ĮWKDQYLWDPLQ&VXSSOHPHQWDWLRQLQVSLWHRIKDYLQJKLJKHU0'$OHYHOV,WPD\SRVVLEO\EH
due to greater sympathetic imbalance rather than generation of ROS system by CIH in this study which is effectively 
counteracted by cilnidipine  as a  L-N type calcium channel blocker than vitamin C [28] 
 
Fig.5:  Schematic diagram outlining the hypothesized pathways by which chronic intermittent hypoxia leads 
to hyperglycemia 
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Hence results from this study can clearly enlightened us the role of CIH induces HIF-ĮVLJQDOLQJSDWKZD\VDQG
altered oxidant/antioxidant balance, possibly stimulate chemoreflex and inhibit baroreflex through either ROS or 
direct chemoactivation of carotid bodies . It also causes sympathetic over activities and alter insulin signaling 
mechanisms and resultant insulin resistance. Our findings on improvement of glucose homeostasis in case of 
simultaneous antioxidant (vitamin C) and N- type calcium channel blocker (cilnidipine) treatment clearly support that 
both sympathetic over activation or oxidative stress are responsible to induce insulin resistance and alter glucose 
metabolism in rats (Fig.4). It has been reported that CIH can also contribute to insulin resistance through lowering 
GLUT 4 expression in rats [29]. 
The present study really clarifies certain aspects of CIH which is clinically important for patients with chronic 
obstructive pulmonary disease or sleep apnoea. The study reveals that CIH is linked to insulin signaling pathways, 
insulin sensitivities and metabolic syndrome in rats perhaps through CIH induced increase generation of ROS or 
sympathetic over activities which may be well controlled by treatment of antioxidant or N-type calcium channel 
blockers [30-31]. Sympathetic over activities may be regulated by either direct influences of CIH via chemoreceptor 
or through increase in HIF-Į or through ROS ( Fig.5). The role of sympathetically mediated breakdown of fat and 
generation of free fatty acids may also influence CIH induced insulin resistance [6]. ROS impact on insulin sensitivity 
may be slightly different from sympathetic actions induced by hypoxia. ROS itself may directly controls insulin 
signaling or stimulate N-type calcium channel and induced sympathetic over activity or even facilitate to further 
increase of HIF-Įexpression [32]. Increase in generation of ROS due to CIH emphasized an impairment in beta cell 
function although the present study did not reveal any changes in insulin level due to CIH. Hence it may be attributed 
purely on decrease insulin sensitivities supported by increase HOMA-IR and insulinogenic-index in present study 
[7,33]  
 
In conclusion, it may be stated that CIH induces impaired insulin sensitivities and resultant hyperglycemia by either 
direct or through HIF-Į7KLVGLVWXUEHGJOXFRVHKRPHRVWDVLVmay be remodeled by antioxidant like vitamin C or N-
type calcium channel blocker like cilnidipine treatment. 
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